As health systems are under increasing pressure to share data across systems to improve and expand their networks of care, CardioNet Inc. and AirStrip have entered into a partnership agreement to develop and co-market an integrated solution for mobile patient monitoring.

 

Medtronic Inc. announced the U.S. Food and Drug Administration (FDA) approval and U.S. launch of its Advisa DR MRI (magnetic resonance imaging) SureScan pacing system. The Advisa MRI system is Medtronic’s second-generation MR-conditional pacemaker and is the first system to combine the most advanced pacing technology with proven MRI access.

Computed tomography (CT) radiation dose can result in unnecessarily high exposures, placing patients at increased risk of cancer and other conditions. Inappropriate radiation doses have raised public concerns and attracted national media attention.

Electronic Medical Records Patient Protection and Affordable Health Care

Hospitals, clinics and office-based physicians are increasingly turning to electronic medical records (EMRs) as they prepare for the impact of the Patient Protection and Affordable Health Care (PPAHC) act, says Albert Woodard, CEO of Atlanta-based Business Computer Applications, a company devoted to digitizing medical records.

The Society of Interventional Radiology (SIR), an international organization of doctors, scientists and allied health professionals dedicated to improving public health through minimally invasive, image-guided treatments, joined as a member of the "Rethink Varicose Veins" coalition, an alliance of organizations united to drive public awareness of the risks of varicose veins and chronic venous insufficiency.
St. Jude Medical EnligHTN II trial Renal Denervation System

St. Jude Medical Inc. announced enrollment of the first patient in the EnligHTN II trial. This post-market clinical study will further evaluate the safety and efficacy of the EnligHTN renal denervation system in patients with uncontrolled hypertension. 

 

St. Jude Medical Inc announced the first patient implant of its 25 mm Portico Transcatheter Aortic Heart Valve using the Transfemoral Delivery System in its ongoing European trial. The Portico valve system offers a minimally invasive treatment option for patients with severe aortic stenosis — a narrowing of the aortic valve that obstructs blood flow from the heart.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now